Verastem announces FDA Fast Track designation for VS-7375
Summary
Verastem says the FDA granted Fast Track designation for VS-7375. The item points to a development-stage pharmaceutical program rather than a software product or SaaS company event. No customer, partner, or procurement activity is indicated in the text. The main significance is regulatory progress for a drug candidate.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected